966
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures

, &
Pages 11-20 | Received 26 Oct 2023, Accepted 19 Jan 2024, Published online: 06 Feb 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.